GAD2 and aceruloplasminemia: The pathogenicity of anti-GAD65 antibodies is related to the recognized antigenic sites, as different epitopes are associated with different diseases, such as stiff person syndrome, cerebellar ataxia, type I diabetes, and thyroiditis (10).